Diabetes Mellitus

Populations and Risk Factors

Type 1: typically diagnosed before age 30 (peak onset 10–14 years); equal sex distribution; autoimmune etiology with strong genetic predisposition (HLA-DR3/DR4 associations); family history is a risk factor but most cases are sporadic
Type 2: prevalence increases sharply after age 45; higher prevalence in Indigenous, African, Hispanic, and South Asian populations; strong association with obesity (especially visceral adiposity), physical inactivity, and metabolic syndrome
Metabolic syndrome cluster — hypertension, dyslipidemia, central obesity, insulin resistance — dramatically increases Type 2 risk and cardiovascular comorbidity
First-degree relatives of Type 2 diabetics have 2–4 times the population risk
Gestational diabetes in a previous pregnancy increases lifetime Type 2 risk by 50%
Medications: corticosteroids, thiazide diuretics, and some antipsychotics can precipitate or worsen hyperglycemia

Causes and Pathophysiology

Insulin Mechanism — Normal Physiology

Insulin is produced by beta cells in the pancreatic islets of Langerhans. When blood glucose rises after a meal, insulin is released into the bloodstream.
Insulin binds to receptors on muscle, liver, and adipose cells, triggering GLUT-4 transporter translocation to the cell surface — this allows glucose to enter the cell for energy production or storage as glycogen (liver, muscle) or triglyceride (adipose).
Without insulin, glucose remains in the bloodstream. Cells are starved despite abundant circulating glucose — this is the central paradox of diabetes.

Type 1 — Autoimmune Beta Cell Destruction

An autoimmune process (T-lymphocyte-mediated) destroys pancreatic beta cells, producing absolute insulin deficiency. By the time symptoms appear, approximately 80–90% of beta cells have been destroyed.
Without any endogenous insulin, glucose cannot enter cells. The body shifts to lipolysis and ketogenesis for fuel, which can produce diabetic ketoacidosis (DKA) — a life-threatening metabolic emergency marked by fruity breath, Kussmaul breathing, and altered consciousness.
Type 1 patients are insulin-dependent for life. They manage with exogenous insulin via injection or insulin pump.

Type 2 — Insulin Resistance Cascade

Stage 1 — Receptor downregulation: Chronic hyperinsulinemia (driven by excess caloric intake, especially refined carbohydrates) causes target cells to downregulate insulin receptors. More insulin is needed to achieve the same glucose uptake — insulin resistance.
Stage 2 — Compensatory hyperinsulinemia: Beta cells increase insulin production to overcome resistance. Blood glucose remains controlled but insulin levels are chronically elevated. This stage can persist for years with no symptoms.
Stage 3 — Beta cell exhaustion: Prolonged overproduction eventually exhausts beta cells. Insulin production declines. Blood glucose rises. Clinical diabetes emerges.
Type 2 patients may eventually require exogenous insulin as beta cell function deteriorates, but many are managed with oral hypoglycemics, GLP-1 agonists, or SGLT2 inhibitors (see Medications below).

Why Peripheral Neuropathy Develops — The Sorbitol Pathway

In sustained hyperglycemia, excess glucose enters nerve cells (Schwann cells) via insulin-independent pathways. Inside Schwann cells, the enzyme aldose reductase converts glucose to sorbitol.
Sorbitol cannot cross cell membranes and accumulates intracellularly, drawing water in by osmosis and causing Schwann cell swelling and damage. This damages the myelin sheath and impairs nerve conduction.
The longest nerves are most vulnerable because they have the greatest metabolic demand and the most Schwann cells exposed — this produces the characteristic stocking-and-glove distribution (feet first, then hands).
Sensory fibers are affected first (numbness, tingling, burning), followed by motor fibers (intrinsic foot muscle weakness, altered gait) and autonomic fibers (anhidrosis, vasomotor dysfunction). See peripheral-neuropathy for full neuropathy assessment.

Why Healing Is Impaired — Microangiopathy

Chronic hyperglycemia causes non-enzymatic glycosylation (glycation) of capillary basement membrane proteins, producing thickening and increased permeability of capillary walls.
Thickened basement membranes reduce oxygen and nutrient delivery to tissues and impair leukocyte migration — the inflammatory response required for healing is blunted.
Combined with macrovascular atherosclerotic changes (also accelerated by diabetes), tissue perfusion is compromised distally. Minor wounds that would heal uneventfully in a non-diabetic client progress to chronic ulceration.
This is why diabetic ulcers typically appear on the feet — the combination of the longest distance from the heart (worst perfusion) and loss of protective sensation (neuropathy) creates a perfect storm.

Why Adhesive Capsulitis and Dupuytren's Occur — Collagen Glycosylation

The same non-enzymatic glycosylation that damages capillary basement membranes also affects collagen throughout the body. Glycosylated collagen fibers become stiffer, form abnormal cross-links, and resist normal remodeling.
In the glenohumeral joint capsule, this produces progressive capsular fibrosis indistinguishable from primary adhesive capsulitis — diabetic patients have a 10–36% incidence of adhesive capsulitis versus 2–5% in the general population.
In the palmar fascia, glycosylated collagen contributes to Dupuytren's contracture (thickening and shortening of the palmar aponeurosis).
Limited joint mobility (LJM) or "diabetic cheiroarthropathy" — stiff, waxy hands with limited finger extension — results from the same mechanism affecting the small joints of the hand. See adhesive-capsulitis and dupuytren-contracture for individual condition management.

Why Foot Ulcers Develop — The Compounding Cascade

Peripheral neuropathy removes protective sensation → the client does not feel injuries, pressure points, or ill-fitting footwear.
Microangiopathy impairs healing → minor injuries that are not felt progress without repair.
Motor neuropathy weakens intrinsic foot muscles → altered biomechanics create abnormal pressure points.
Autonomic neuropathy reduces sweating → skin becomes dry, cracks, and provides an entry point for infection.
The result: undetected injuries progress to chronic ulceration, infection, and in severe cases, gangrene requiring amputation. Foot inspection is a non-negotiable part of every diabetic client assessment.

Signs and Symptoms

Systemic Metabolic Signs

Polyuria: osmotic diuresis — excess glucose in the renal filtrate draws water, producing large volumes of dilute urine
Polydipsia: compensatory thirst from fluid loss
Polyphagia: cellular starvation despite high blood glucose drives excessive appetite (more prominent in Type 1)
Unexplained weight loss (Type 1) or difficulty losing weight (Type 2)
Fatigue, blurred vision, slow wound healing

Neurological Effects

Peripheral neuropathy in a stocking-and-glove distribution — numbness, tingling, burning, loss of protective sensation; feet affected first
Autonomic neuropathy — postural hypotension, gastroparesis, anhidrosis, erectile dysfunction
Motor neuropathy — intrinsic foot muscle atrophy, claw toe deformity, altered gait mechanics

Musculoskeletal Effects

Adhesive capsulitis (frozen shoulder) — 10–36% of diabetic patients; often bilateral; may be the presenting complaint that leads to diabetes diagnosis
Dupuytren's contracture — thickening of palmar fascia with progressive finger flexion contracture
Limited joint mobility (cheiroarthropathy) — waxy, tight skin over hands with limited MCP and IP extension
Carpal tunnel syndrome — increased prevalence due to glycosylation of flexor retinaculum and synovium

Integumentary Effects

Delayed wound healing — minor cuts, blisters, and pressure sores heal slowly or not at all
Diabetic ulcers — typically plantar foot, painless (neuropathic), punched-out appearance; may be infected
Acanthosis nigricans — dark, velvety, thickened skin in body folds (neck, axilla, groin); associated with insulin resistance (Type 2)
Thin, shiny, hairless skin on lower extremities from chronic ischemia
Dry, cracked skin on feet from autonomic neuropathy (reduced sweating)

Cardiovascular Effects

Peripheral edema — from microangiopathy, renal involvement, or cardiac comorbidity
Cold extremities — reduced peripheral perfusion from micro- and macrovascular disease
Hypertension — present in the majority of Type 2 diabetics; part of the metabolic syndrome cluster
Accelerated atherosclerosis — 2–4 times the cardiovascular disease risk of non-diabetic population

Assessment Profile

This Assessment Profile evaluates the physical effects of diabetes on the body — neurological, musculoskeletal, integumentary, and cardiovascular. It does not assess or diagnose diabetes itself, which is a medical diagnosis confirmed by blood testing (HbA1c, fasting glucose).

Subjective Presentation

Chief complaint: Highly variable depending on which system is most affected. Client may present for: shoulder stiffness (developing adhesive capsulitis), foot numbness or burning (peripheral neuropathy), general muscle tension, or circulatory support. Many diabetic clients present with a known diagnosis and are seeking adjunctive care; some may present with undiagnosed diabetes showing early poly symptoms or unexplained neuropathy.
Pain quality: Neuropathic pain is burning, electric, or "pins and needles" in a stocking-and-glove distribution; musculoskeletal pain is deep aching in affected joints (shoulder, hands); may report painless areas that should be painful (loss of protective sensation) — this is itself a critical finding.
Onset: Insidious for Type 2 — symptoms develop over months to years; Type 1 onset is more acute (weeks to months). Musculoskeletal complications (adhesive capsulitis, Dupuytren's) develop gradually over months. Neuropathic symptoms progress distally to proximally over time.
Aggravating factors: Prolonged standing or walking worsens foot symptoms; sustained positions aggravate joint stiffness; poorly controlled blood sugar accelerates all complications; cold environments worsen circulatory symptoms in the extremities.
Easing factors: Elevation reduces edema; gentle movement reduces joint stiffness (unlike inflammatory arthritis, which worsens with activity initially); optimal glycemic control slows progression of all complications.
Red flags: Signs of hypoglycemia (shakiness, sweating, confusion, pallor, rapid onset) → stop treatment immediately; provide sugar/juice; call emergency services if consciousness is impaired. Signs of diabetic ketoacidosis (fruity breath, rapid deep breathing, confusion, nausea) → emergency referral; do not treat. Non-healing ulcers with signs of infection (redness, warmth, purulent drainage, foul odor) → medical referral before treatment.

Observation

Local inspection: Inspect feet carefully — look for ulcers, calluses over pressure points, cracks in dry skin, claw toe deformity, nail changes; inspect skin for acanthosis nigricans (dark velvety patches in neck/axillary folds); note thin, shiny, hairless skin on lower legs; check for edema in ankles and feet; identify insulin injection sites (abdomen, thighs, upper arms) and insulin pump locations — these are local contraindications. If no visible changes, state that explicitly.
Posture: Shoulder posture may show bilateral protective guarding if adhesive capsulitis is developing; forward head posture from fatigue; antalgic stance if foot ulcers or neuropathy alter weight-bearing; kyphotic tendency in long-standing diabetes with osteoporotic changes.
Gait: Steppage gait if motor neuropathy produces foot drop; wide-based cautious gait from proprioceptive loss; antalgic gait avoiding pressure on ulcerated areas; shuffling gait from loss of ankle dorsiflexion strength. Observe footwear — ill-fitting shoes are a primary ulcer risk factor.

Palpation

Tone: Generalized tension patterns from chronic pain and fatigue rather than focal hypertonia; shoulder girdle musculature (upper trapezius, levator scapulae, pectoralis minor) may show guarding if adhesive capsulitis is developing; intrinsic foot muscles may be atrophied and hypotonic from motor neuropathy
Tenderness: Neuropathic areas may show paradoxical findings — hyposensitivity (cannot feel normal pressure) or hypersensitivity (allodynia/hyperalgesia in areas of active neuropathic pain); always perform sensation testing before applying pressure to the extremities (see SOT cluster); shoulder capsule tenderness if capsulitis is present; plantar tenderness at callus sites over bony prominences
Temperature: Cool feet and lower legs from microangiopathy and macrovascular disease — compare bilaterally and compare distal to proximal gradient; temperature difference between proximal and distal limb segments reflects severity of circulatory compromise; warm areas around wounds suggest active infection — do not treat infected tissue
Tissue quality: Skin may be thin, fragile, and easily damaged (reduced collagen integrity from glycosylation); pitting edema in dependent areas; dry, inelastic skin on feet from autonomic neuropathy; waxy, tight skin over hands in cheiroarthropathy; thickened palmar fascia if Dupuytren's is present; shoulder capsular thickening palpable in axillary fold if adhesive capsulitis is developing

Motion Assessment

AROM: Shoulder ROM screen — if adhesive capsulitis is developing, external rotation is restricted first, followed by abduction and internal rotation (capsular pattern of the GH joint); hand and finger ROM — limited MCP/IP extension in cheiroarthropathy ("prayer sign" — inability to fully flatten palms together); foot and ankle ROM — reduced dorsiflexion from plantarflexor tightness or Achilles tendon glycosylation; reduced toe extension from intrinsic muscle atrophy
PROM / end-feel: Shoulder: capsular/leathery end-feel in all directions if adhesive capsulitis is established — PROM equals AROM (distinguishes capsulitis from rotator cuff pathology where PROM exceeds AROM); hand joints: firm/bony end-feel from collagen changes; ankle: may be elastic-muscular (tight gastrocnemius/soleus) or firm (tendon/capsular glycosylation)
Resisted testing: Generally normal unless motor neuropathy is advanced; intrinsic foot muscle weakness (inability to spread toes, weak toe flexion) indicates motor fiber involvement; grip strength may be reduced if carpal tunnel or cheiroarthropathy is present; shoulder strength testing is relevant only if adhesive capsulitis differential includes rotator cuff pathology

Special Test Cluster

The diabetic SOT cluster screens for the physical complications of diabetes rather than confirming the diagnosis itself. Tests are oriented toward detecting neuropathy severity, circulatory compromise, and developing musculoskeletal complications.

Test	Positive Finding	Purpose
Semmes-Weinstein Monofilament Test (CMTO)	Inability to detect the 10g (5.07) monofilament at any of the standard plantar test sites — indicates loss of protective sensation	Confirm peripheral neuropathy and quantify sensory loss; inability to detect 10g monofilament = high ulcer risk
Vibration Sense Testing (128 Hz tuning fork) (CMTO)	Reduced or absent vibration perception at the great toe, medial malleolus, or tibial tuberosity — compare bilaterally	Confirm large-fiber neuropathy; vibration loss precedes monofilament loss and serves as an early detection tool
Capsular Pattern Screen — GH Joint (CMTO — if shoulder involved)	External rotation most restricted > abduction > internal rotation; PROM = AROM; capsular/leathery end-feel in all restricted directions	Differentiate adhesive capsulitis from rotator cuff pathology; capsulitis shows equal active and passive restriction
Skin Turgor and Hydration Assessment (supplementary)	Decreased skin turgor (tenting on dorsum of hand); dry, cracked plantar skin; thin, fragile skin on shins	Screen integumentary integrity; guides pressure limitations and identifies ulcer risk areas
Pedal Pulse Assessment (dorsalis pedis, posterior tibial) (supplementary)	Weak or absent pedal pulses compared to proximal pulses; capillary refill > 3 seconds in toes	Screen for peripheral vascular compromise; absent pulses with skin changes = significant macrovascular disease — medical referral

Conditional cluster — if neurological signs extend beyond expected diabetic neuropathy pattern: If sensory loss is asymmetric, rapidly progressive, or accompanied by UMN signs (hyperreflexia, positive Babinski), the presentation may not be diabetic neuropathy alone. Add deep tendon reflexes and Babinski sign to differentiate from spinal cord pathology, MS, or other CNS conditions. Diabetic neuropathy produces LMN signs (hyporeflexia, negative Babinski).

Differential Diagnoses

Condition	Key Distinguishing Feature
Peripheral neuropathy (non-diabetic)	Identical presentation possible — distinguish by history (no diabetes diagnosis, no hyperglycemia); causes include B12 deficiency (macrocytic anemia, low serum B12), alcoholism (history of heavy use, liver changes), hypothyroidism (fatigue, weight gain, cold intolerance, elevated TSH)
Peripheral artery disease (non-diabetic)	Intermittent claudication with predictable walking distance; ABI < 0.9; absent pedal pulses; smoking history without diabetes; may coexist with diabetes
Hypothyroidism	Fatigue, weight gain, cold intolerance, constipation, dry skin overlap with some diabetic symptoms; TSH elevated; no hyperglycemia or neuropathy pattern
Alcoholic neuropathy	Stocking-and-glove pattern identical to diabetic neuropathy; history of chronic heavy alcohol use; often coexists with nutritional deficiencies (B1, B12); may have liver disease signs
Primary adhesive capsulitis	Identical shoulder presentation; distinguished by absence of diabetes diagnosis and other diabetic complications; primary capsulitis is typically unilateral; diabetic capsulitis is more often bilateral and more resistant to treatment

CMTO Exam Relevance

CMTO Appendix category A3 (systemic/metabolic conditions); complications cross into A1 (adhesive capsulitis, Dupuytren's) and A4 (peripheral neuropathy)
Hypoglycemia recognition is heavily tested — know the signs (shakiness, sweating, confusion, pallor, rapid onset) and the immediate response (stop treatment, provide fast-acting sugar, call emergency services if consciousness impaired); distinguish from hyperglycemic ketoacidosis (gradual onset, fruity breath, Kussmaul breathing)
Know that massage can lower blood sugar — have a sugar source available for every diabetic client session; this is an exam expectation
Insulin injection sites and pump sites are local contraindications — identify and avoid; common sites: abdomen, anterior thigh, posterior upper arm, buttocks
Stocking-and-glove neuropathy pattern is a classic exam question — know that it reflects longest-nerve-first vulnerability (sorbitol pathway)
Adhesive capsulitis in a diabetic patient has a different prognosis — more resistant to treatment, more likely bilateral, and the capsular pattern (ER > Abd > IR) remains a frequently tested concept
Type 1 vs. Type 2 distinction is tested: autoimmune destruction (absolute deficiency, ketoacidosis risk) vs. insulin resistance cascade (relative deficiency, hyperosmolar risk)

Medications — MT-Relevant Updates

Insulin (injected or pumped): lowers blood sugar; injection and pump sites are local contraindications; massage-induced blood sugar lowering compounds the insulin effect — heightened hypoglycemia risk
Metformin (Glucophage): first-line oral for Type 2; generally well-tolerated; rarely causes hypoglycemia alone
Sulfonylureas (glyburide, glipizide): stimulate insulin release; significant hypoglycemia risk, especially with massage
GLP-1 receptor agonists (semaglutide/Ozempic, tirzepatide/Mounjaro): newer injectable medications that slow gastric emptying, increase insulin secretion, and reduce appetite; increasingly common; associated with significant weight loss; GI side effects (nausea, vomiting) may affect positioning comfort; injection sites (abdomen, thigh) are local contraindications
SGLT2 inhibitors (empagliflozin/Jardiance, dapagliflozin/Farxiga): block glucose reabsorption in the kidneys, causing glucose excretion in urine; increase urination frequency (polyuria may persist even with controlled blood sugar); dehydration risk — ensure client is hydrated; rare risk of genital infections and euglycemic DKA
Thiazolidinediones (pioglitazone/Actos): improve insulin sensitivity; can cause fluid retention and peripheral edema; edema may worsen with dependent positioning

Massage Therapy Considerations

Primary therapeutic target: the compounding effects of impaired circulation and impaired sensation — massage supports peripheral circulation, maintains tissue health in vulnerable areas, addresses musculoskeletal complications (capsulitis, Dupuytren's, joint stiffness), and provides systemic relaxation that supports glycemic regulation
Sequencing logic: begin with general relaxation and systemic circulation support before addressing specific complications; assess sensation and skin integrity before working the extremities; address shoulder capsulitis or hand involvement only after establishing that the client tolerates the work; foot work comes last and only after thorough inspection — this order protects the most vulnerable tissues
Pressure limitation principle: impaired sensation means the client cannot provide reliable pain feedback in affected areas. The standard "pressure to client tolerance" model does not apply to insensate areas. Use visual tissue response (blanching, redness, edema) rather than verbal feedback to gauge pressure. Lighter pressure overall — tissue is more fragile due to microangiopathy and glycosylated collagen.
Hypoglycemia preparedness — the #1 MT safety rule for diabetes: have fast-acting sugar available at every session (juice, glucose tablets, candy); know the signs (shakiness, sweating, confusion, pallor); stop treatment immediately if signs appear; do not resume until blood sugar is confirmed stable. Massage can lower blood sugar through improved insulin sensitivity and glucose uptake — this effect is therapeutic but requires vigilance.
Insulin injection and pump sites: identify at every session (sites rotate); maintain a minimum 5 cm clearance; these are absolute local contraindications — pressure can alter insulin absorption rate and cause unpredictable blood sugar changes
Heat and hydrotherapy: warm hydrotherapy is permissible ONLY if sensation has been confirmed in the treatment area — test water temperature on an unaffected area first; NO heat to insensate areas (the client cannot detect thermal injury); NO heat to areas with compromised circulation (impaired ability to dissipate heat)
Contraindications: do not massage over ulcers, infected skin, or areas of active cellulitis; avoid deep pressure over areas of absent sensation; avoid vigorous techniques that may cause tissue damage in fragile skin; do not massage edematous limbs if cause is unknown (rule out DVT, renal, or cardiac origin first)

Treatment Plan Foundation

Clinical Goals

Support peripheral circulation in the extremities to counteract microangiopathy
Maintain tissue health and skin integrity in neuropathic areas through gentle stimulation
Address musculoskeletal complications (shoulder capsulitis, hand stiffness, foot mechanics) within safe pressure limits
Provide systemic parasympathetic activation to support stress-mediated glycemic regulation

Position

Supine to start — allows foot inspection, pedal pulse assessment, and lower extremity observation before treatment
Position changes to prone or side-lying as tolerated; side-lying preferred if prone is uncomfortable due to neuropathic pain or injection site locations
Bolster feet off the table surface to avoid pressure on vulnerable plantar skin; heel protectors if available
Ensure easy access to sugar source — do not position client in a way that delays hypoglycemia response

Session Sequence

General effleurage to posterior trunk — establish baseline relaxation; assess general tissue quality and skin integrity before proceeding to extremities
Effleurage and petrissage to proximal lower extremities (thighs) — begin circulation support proximally where sensation and tissue integrity are most preserved; assess temperature gradient moving distally
Gentle effleurage to lower legs — lighter pressure moving distally; assess skin condition (thin/shiny/hairless = significant ischemia); note temperature changes; avoid any areas of broken skin, ulceration, or active infection
Careful foot work — only if inspection confirms no ulcers, open wounds, or active infection; gentle effleurage and light petrissage to plantar and dorsal surfaces; pressure guided by tissue response rather than client feedback in insensate areas; focus on maintaining tissue mobility and circulation
Upper extremity circulation work — effleurage and petrissage to forearms and hands; address palmar fascia if Dupuytren's thickening is present (gentle cross-fiber to the palmar aponeurosis); gentle finger mobilization if cheiroarthropathy limits ROM
Shoulder capsulitis protocol — [only if capsulitis is identified] — release pectoralis minor, subscapularis (axillary access required — see Verbal Notes), and posterior capsule musculature before any capsular mobilization; follow the principles in adhesive-capsulitis adapted for diabetic tissue fragility
Cervical and upper back tension — address compensatory patterns from shoulder guarding, fatigue posture, and systemic stress
Reassessment — check distal skin color and temperature; confirm client is alert and oriented (screen for hypoglycemia before discharge)

Adjunct Modalities

Hydrotherapy: warm (not hot) moist towel application to proximal segments where sensation is confirmed — improves tissue pliability before deep work; NO heat to insensate areas or areas with compromised circulation; test water temperature on the client's unaffected forearm before applying to feet or lower legs; cool towel application post-treatment to any area that shows reactive hyperemia; contrast hydrotherapy (warm-cool alternation) to proximal lower extremities may support circulatory response — confirm sensation first
Joint mobilization: gentle PROM to shoulder (inferior glide, Grade I–II) if capsulitis is developing — performed after soft tissue release; gentle PROM to MCP and IP joints if cheiroarthropathy is present — slow, sustained mobilization within available range; gentle ankle dorsiflexion mobilization to maintain range against plantarflexor tightness — do not force against glycosylated tendon tissue
Remedial exercise (on-table): active-assisted ankle pumps to support venous return and maintain ankle ROM; gentle active finger extension exercises if cheiroarthropathy is present; PIR (post-isometric relaxation) to pectoralis minor and subscapularis if shoulder capsulitis is being addressed — use submaximal contractions given tissue fragility

Exam Station Notes

Demonstrate foot inspection protocol — the examiner expects to see visual inspection of both feet before any foot treatment; verbalize what you are looking for (ulcers, skin breaks, calluses, color changes, deformity)
Demonstrate sensation testing — Semmes-Weinstein monofilament or light touch testing before applying pressure to the feet; verbalize the clinical reasoning ("I need to confirm sensation before I can rely on your feedback to guide pressure")
Have a visible sugar source available — the examiner expects this for any diabetic client scenario; verbalize awareness that massage can lower blood sugar
Identify and avoid injection/pump sites — ask the client where they are currently injecting; verbalize the local contraindication

Verbal Notes

Hypoglycemia protocol: at the start of every session: "When was your last meal, and what was your blood sugar reading? I keep juice and glucose tablets here because massage can sometimes lower blood sugar. If you start feeling shaky, sweaty, lightheaded, or confused during the session, tell me immediately — we'll stop and get some sugar into you right away."
Injection/pump site identification: "Where are your current injection sites [or where is your pump placed today]? I'll make sure to avoid those areas completely."
Pressure limitation: "Because diabetes can affect sensation in the hands and feet, I'm going to use lighter pressure in those areas. You may not be able to feel exactly how much pressure I'm applying, so I'll be watching your tissue response carefully. If anything feels uncomfortable at all, let me know."
Foot inspection: "I'd like to check your feet before we start working on them. This is standard care for diabetic clients — I'm looking at skin condition, any areas of concern, and circulation. Is that okay?"

Self-Care

Daily foot inspection — check between toes, under foot, and around nails for cuts, blisters, calluses, or color changes; use a mirror for the sole if flexibility is limited; report any non-healing wound to their physician immediately
Gentle daily ankle pumps and toe exercises to support peripheral circulation — 10–15 repetitions, 2–3 times daily
Moisturize feet daily (but not between toes) to prevent cracking from autonomic neuropathy-related dry skin; never walk barefoot
If adhesive capsulitis is developing: daily pendulum exercises (Codman's) and gentle towel-assisted external rotation stretches per the adhesive-capsulitis self-care protocol

Key Takeaways

Diabetes mellitus is a cross-system condition — peripheral neuropathy, microangiopathy, collagen glycosylation, and impaired healing compound in a single client, and the MT must assess and manage all of them simultaneously
The sorbitol pathway explains diabetic neuropathy: excess glucose → aldose reductase → sorbitol accumulation in Schwann cells → myelin damage → stocking-and-glove sensory loss (longest nerves first)
Massage can lower blood sugar — have fast-acting sugar available at every session; recognize hypoglycemia (shakiness, sweating, confusion) and respond immediately
Insulin injection sites and pump sites are absolute local contraindications — identify at every session and maintain clearance
Impaired sensation means standard "pressure to client tolerance" does not apply — use visual tissue response (blanching, redness) to gauge pressure in insensate areas
Foot inspection is non-negotiable before any foot work — look for ulcers, skin breaks, calluses, deformity, and circulatory signs
Adhesive capsulitis occurs in 10–36% of diabetics due to collagen glycosylation — expect bilateral involvement and greater treatment resistance than primary capsulitis
Heat modalities require confirmed sensation in the treatment area — no heat to insensate or ischemic areas; test temperature on unaffected skin first